135 related articles for article (PubMed ID: 29453678)
1. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
[TBL] [Abstract][Full Text] [Related]
2. Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas.
Cai J; Zhu P; Zhang C; Li Q; Wang Z; Li G; Wang G; Yang P; Li J; Han B; Jiang C; Sun Y; Jiang T
Oncotarget; 2016 Mar; 7(13):16384-95. PubMed ID: 26918938
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma.
Chuntova P; Yamamichi A; Chen T; Narayanaswamy R; Ronseaux S; Hudson C; Tron AE; Hyer ML; Montoya M; Mende AL; Nejo T; Downey KM; Diebold D; Lu M; Nicolay B; Okada H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35606087
[TBL] [Abstract][Full Text] [Related]
4. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM
Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the REST transcription factor regulatory networks in IDH mutant and IDH wild-type glioma cell lines and tumors.
Perycz M; Dabrowski MJ; Jardanowska-Kotuniak M; Roura AJ; Gielniewski B; Stepniak K; Dramiński M; Ciechomska IA; Kaminska B; Wojtas B
Acta Neuropathol Commun; 2024 May; 12(1):72. PubMed ID: 38711090
[TBL] [Abstract][Full Text] [Related]
6. Mutant IDH1 and thrombosis in gliomas.
Unruh D; Schwarze SR; Khoury L; Thomas C; Wu M; Chen L; Chen R; Liu Y; Schwartz MA; Amidei C; Kumthekar P; Benjamin CG; Song K; Dawson C; Rispoli JM; Fatterpekar G; Golfinos JG; Kondziolka D; Karajannis M; Pacione D; Zagzag D; McIntyre T; Snuderl M; Horbinski C
Acta Neuropathol; 2016 Dec; 132(6):917-930. PubMed ID: 27664011
[TBL] [Abstract][Full Text] [Related]
7. Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis.
Liu Z; Che P; Mercado JJ; Hackney JR; Friedman GK; Zhang C; You Z; Zhao X; Ding Q; Kim K; Li H; Liu X; Markert JM; Nabors B; Gillespie GY; Zhao R; Han X
J Neurooncol; 2019 Jan; 141(2):289-301. PubMed ID: 30460631
[TBL] [Abstract][Full Text] [Related]
8. Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.
Euskirchen P; Radke J; Schmidt MS; Schulze Heuling E; Kadikowski E; Maricos M; Knab F; Grittner U; Zerbe N; Czabanka M; Dieterich C; Miletic H; Mørk S; Koch A; Endres M; Harms C
PLoS One; 2017; 12(9):e0185376. PubMed ID: 28945795
[TBL] [Abstract][Full Text] [Related]
9. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.
Zhao S; Lin Y; Xu W; Jiang W; Zha Z; Wang P; Yu W; Li Z; Gong L; Peng Y; Ding J; Lei Q; Guan KL; Xiong Y
Science; 2009 Apr; 324(5924):261-5. PubMed ID: 19359588
[TBL] [Abstract][Full Text] [Related]
10. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
Rohle D; Popovici-Muller J; Palaskas N; Turcan S; Grommes C; Campos C; Tsoi J; Clark O; Oldrini B; Komisopoulou E; Kunii K; Pedraza A; Schalm S; Silverman L; Miller A; Wang F; Yang H; Chen Y; Kernytsky A; Rosenblum MK; Liu W; Biller SA; Su SM; Brennan CW; Chan TA; Graeber TG; Yen KE; Mellinghoff IK
Science; 2013 May; 340(6132):626-30. PubMed ID: 23558169
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of JAM-A in gliomas.
Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of transcriptomic profile, histology, and IDH mutation for classification of gliomas.
Tran PMH; Tran LKH; Nechtman J; Dos Santos B; Purohit S; Satter KB; Dun B; Kolhe R; Sharma S; Bollag R; She JX
Sci Rep; 2020 Nov; 10(1):20651. PubMed ID: 33244057
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia is associated with hypomethylation of TWEAK and increased plasma levels of TWEAK and its downstream inflammatory factor TNF-α in older adults: A case-control study.
Xuekelati S; Maimaitiwusiman Z; Bai X; Xiang H; Li Y; Wang H
Exp Gerontol; 2024 Apr; 188():112390. PubMed ID: 38437928
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic
Beyer SJ; Bell EH; McElroy JP; Fleming JL; Cui T; Becker A; Bassett E; Johnson B; Gulati P; Popp I; Staszewski O; Prinz M; Grosu AL; Haque SJ; Chakravarti A
Oncotarget; 2018 Dec; 9(98):37097-37111. PubMed ID: 30647847
[TBL] [Abstract][Full Text] [Related]
15. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.
Martínez-Aranda A; Hernández V; Guney E; Muixí L; Foj R; Baixeras N; Cuadras D; Moreno V; Urruticoechea A; Gil M; Oliva B; Moreno F; González-Suarez E; Vidal N; Andreu X; Seguí MA; Ballester R; Castella E; Sierra A
Oncotarget; 2015 Dec; 6(42):44254-73. PubMed ID: 26497551
[TBL] [Abstract][Full Text] [Related]
16. A noncoding single-nucleotide polymorphism at 8q24 drives
Yanchus C; Drucker KL; Kollmeyer TM; Tsai R; Winick-Ng W; Liang M; Malik A; Pawling J; De Lorenzo SB; Ali A; Decker PA; Kosel ML; Panda A; Al-Zahrani KN; Jiang L; Browning JWL; Lowden C; Geuenich M; Hernandez JJ; Gosio JT; Ahmed M; Loganathan SK; Berman J; Trcka D; Michealraj KA; Fortin J; Carson B; Hollingsworth EW; Jacinto S; Mazrooei P; Zhou L; Elia A; Lupien M; He HH; Murphy DJ; Wang L; Abyzov A; Dennis JW; Maass PG; Campbell K; Wilson MD; Lachance DH; Wrensch M; Wiencke J; Mak T; Pennacchio LA; Dickel DE; Visel A; Wrana J; Taylor MD; Zadeh G; Dirks P; Eckel-Passow JE; Attisano L; Pombo A; Ida CM; Kvon EZ; Jenkins RB; Schramek D
Science; 2022 Oct; 378(6615):68-78. PubMed ID: 36201590
[TBL] [Abstract][Full Text] [Related]
17. Integrated genomic characterization of IDH1-mutant glioma malignant progression.
Bai H; Harmancı AS; Erson-Omay EZ; Li J; Coşkun S; Simon M; Krischek B; Özduman K; Omay SB; Sorensen EA; Turcan Ş; Bakırcığlu M; Carrión-Grant G; Murray PB; Clark VE; Ercan-Sencicek AG; Knight J; Sencar L; Altınok S; Kaulen LD; Gülez B; Timmer M; Schramm J; Mishra-Gorur K; Henegariu O; Moliterno J; Louvi A; Chan TA; Tannheimer SL; Pamir MN; Vortmeyer AO; Bilguvar K; Yasuno K; Günel M
Nat Genet; 2016 Jan; 48(1):59-66. PubMed ID: 26618343
[TBL] [Abstract][Full Text] [Related]
18. Pediatric high grade gliomas: A comprehensive histopathological, immunohistochemical and molecular integrated approach in routine practice.
Das S; Ahlawat S; Panda AK; Sarangi J; Jain P; Gupta RK; Vaishya S; Patir R
Pathol Res Pract; 2024 Jun; 258():155347. PubMed ID: 38763090
[TBL] [Abstract][Full Text] [Related]
19. Advances in Brain Cancer: Creating Monoallelic Single Point Mutation in IDH1 by Single Base Editing.
Shah SR; Quinones-Hinojosa A; Xia S
J Oncol Res Ther; 2019; 5(5):. PubMed ID: 31328182
[TBL] [Abstract][Full Text] [Related]
20. Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.
Miroshnikova YA; Mouw JK; Barnes JM; Pickup MW; Lakins JN; Kim Y; Lobo K; Persson AI; Reis GF; McKnight TR; Holland EC; Phillips JJ; Weaver VM
Nat Cell Biol; 2016 Dec; 18(12):1336-1345. PubMed ID: 27820599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]